Work

406 Phase 2 study of XL184 in a cohort of patients (pts) with castration resistant prostate cancer (CRPC) and measurable soft tissue disease

Year: 2010

Type: conference-abstract

Source: European Journal of Cancer Supplements

DOI: 10.1016/s1359-6349(10)72113-3

Authors: D.C. Smith, A. Spira, J. De Grève, L. Hart, S. Holbrechts, C.C. Lin, M. Hussain, S. Herrick, K. Houggy, N. Vogelzang

Institutions: University of Michigan, Artesis Plantijn Hogeschool Antwerpen, National Taiwan University Hospital, Exelixis (United States)

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2078510094

Cites:

Cited by: 8

Related to: 10